10.1016/s0021-9258(18)46856-1 40 LeslieE.DeeleyR
The diagnosis of deficiency is usually clinical, and it is treated with oral, intramuscular, or intravenous supplementation, typically with 3001,000 mg/day for 1 month
GRT-R910 protected against SARS-CoV-2 infection in macaques when used as a homologous prime-boost or as a single boost to a chimpanzee adenovirus-encoded spike [157]
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: an exploratory clinical trial
Protein oxidation in aging, disease, and oxidative stress
The treatment program depends on a patient's current condition, medical history and comorbidities